Ryan Hisner on Twitter
Covid19-Sources
Cultured Human Airway Epithelial Cells (Calu-3): A Model of Human Respiratory Function, Structure, and Inflammatory Responses
COVID-19 mitigation behaviors and policies limited SARS-CoV-2 transmission in the United States from September 2020 through November 2021
Thread by @jeffgilchrist on Thread Reader App
Jeff Gilchrist on Twitter
DE: Nanobiosensor zum Nachweis von SARS-CoV-2 entwickelt
Plasmapheresis to remove amyloid fibrin(ogen) particles for treating the post‐COVID‐19 condition
Emerging Links Between COVID-19 and Cardiovascular & Cerebrovascular Thromboembolic Events: A Systematic Review
Efficacy and safety of Paxlovid in severe adult patients with SARS-Cov-2 infection: a multicenter randomized controlled study
How Covid Affects the Heart (Gift Article)
Study Finds Post-COVID Fatigue Lasts Up to 20 Months
Azvudine is a thymus-homing anti-SARS-CoV-2 drug effective in treating COVID-19 patients
Azvudine versus Paxlovid for oral treatment of COVID-19 in Chinese patients with pre-existing comorbidities
Azvudine
Emergence of neutralizing antibodies associates with clearance of SARS-CoV-2 during HIV-mediated immunosuppression
Covid-19: Ein Rebound ist erstaunlich häufig – auch ohne Paxlovid
Are intelligent people more likely to get vaccinated? The association between COVID-19 vaccine adherence and cognitive profiles
ResultsAdherent (vs. nonadherent) personnel presented higher GIS (mean 5.68 ± 1.84 vs. 4.72 ± 1.91) and MSS (median 26 (IQR 23–29) vs. 24 (IQR 19–26)), p < 0.001 for both. Higher intelligence was the strongest predictor for vaccine adherence (OR = 5.38, 95 %CI 5.11–5.67, p < 0.001). The probability for vaccine adherence increased in association with escalating GIS scores, with highest GIS females more likely to adhere to vaccination than same-level males (OR = 5.66, 95 %CI 5.09–6.28 vs. OR = 3.69, 95 %CI 3.45–3.94, respectively, p < 0.001 for both). Medically fit service-members were approximately three times as likely to be adherent than volunteering personnel (OR = 2.90 (95 %CI 2.65–3.17) for administrative and OR = 2.94 (95 %CI 2.70–3.21) for combative fitness, p < 0.001 for both).
The potential clinical impact and cost-effectiveness of the updated COVID-19 mRNA Fall 2023 vaccines in the United States
Type 1 Diabetes Incidence and Risk in Children With a Diagnosis of COVID-19
Science | AAAS
Severe COVID-19 Linked to Undiagnosed Cancer
Neue "Pirola"-Variante alarmiert Experten: Israel ordnet wieder Corona-Regeln an
Analyse der Übersterblichkeit während der COVID-19-Pandemie in Deutschland, 2020–2022
Kinetics and durability of humoral responses to SARS-CoV-2 infection and vaccination
Hospital-Onset SARS-CoV-2 Infection Rates and Testing Practices in the US
Mucosal antibody responses to SARS-CoV-2 booster vaccination and breakthrough infection
Übersterblichkeit während Corona: Studie sieht Zusammenhang mit Covid-19, nicht mit Impfungen
Barmer Studie
Vaccine-induced correlate of protection against fatal COVID-19 in older and frail adults during waves of neutralization-resistant variants of concern: an observational study
Vaccine-induced correlate of protection against fatal COVID-19 in older and frail adults during waves of neutralization-resistant variants of concern: an observational study
Highlighting COVID-19 racial disparities can reduce support for safety precautions among White U.S. residents
SARS-CoV-2-Induced Immunosuppression: A Molecular Mimicry Syndrome